Glioma Pipeline Landscape Report 2024: Comprehensive Market Insights on 180+ Companies and Respective 200+ Pipeline Drugs
April 24, 2024 11:36 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Glioma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Glioma - Pipeline Insight, 2024" report...
High-Grade Glioma Pipeline Research 2024: Comprehensive Insights About 150+ Companies and 150+ Drugs
April 22, 2024 09:23 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "High-Grade Glioma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "High-grade Glioma - Pipeline...
Adult Malignant Glioma Therapeutics Global Market Report 2024: Significant Growth by 2028 Driven by Advances in Immunotherapy and Targeted Therapies
March 19, 2024 18:03 ET
|
Research and Markets
Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "Adult Malignant Glioma Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The adult malignant glioma...
Global Glioma Competitive Landscape Report 2023: Insights About 200+ Companies and 220+ Drug Profiles - Assessment by Product Type, Stage, Route of Administration, and Molecule Type
May 08, 2023 06:58 ET
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Glioma - Competitive Landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Glioma - Competitive landscape, 2023" report...